Simultaneous Rapid Separation and Determination of Fosphenytoin,Phenytoin and Their Main Metabolite 4′-Hydroxyphenytoin in Human Plasma Using Reversed-Phase HPLC

M Chun-li;JIO Zheng;YING Yin-qing;SHI Xio-Jin

Chinese Pharmaceutical Journal ›› 2008, Vol. 43 ›› Issue (22) : 1743-1746.

Chinese Pharmaceutical Journal ›› 2008, Vol. 43 ›› Issue (22) : 1743-1746.
论著

Simultaneous Rapid Separation and Determination of Fosphenytoin,Phenytoin and Their Main Metabolite 4′-Hydroxyphenytoin in Human Plasma Using Reversed-Phase HPLC

  • MA Chun-lai1,JIAO Zheng1*,YING Yin-qing2,SHI Xiao-Jin1
Author information +
History +

Abstract

OBJECTIVE To develop a simple reversed-phase high-performance liquid chromatography(HPLC) method for thesimultaneous determination of the antiepileptic drugs(AEDs) phenytoin(PHT),its prodrug fosphenytoin(FOS),and its metabolite 4′-hydroxyphenytoin(4′-HPPH) in human plasma.METHODS Plasma sample(100 μL) pre-treatment involved acidification with 20% phosphoric acid,simple extraction with 1 mL of acetic ester containing 10 mg·L-1 propranolol hydrochloride as internal standard and evaporation of solvent,followed by injection of reconstituted sample onto a Agilent RX-C8 column(4.6 mm × 250 mm,5 μm).The mobile phase consisted of methanol-acetonitrile-0.1% triflouroacetic acid(23∶17∶60),and delivered at a 1.5 mL·min-1.The analytes were detected at the wavelength of 210 nm.RESULTS The method was found to be linear over the concentration ranges investigated,1-400 mg·L-1 for FOS,0.5-50 mg·L-1 for PHT and 0.5-10 mg·L-1 for 4′-HPPH,respectively.The intra-and inter-day reproducibility was good with the RSD of 8% or below and relative recovery was ranged from 92.79% to 107.90% for all analytes.CONCLUSION This method was proved to be accurate,sensitive and convenient and suitable for clinical therapeutic drug monitoring.

Key words

fosphenytoin / phenytoin / 4′-hydroxyphenytoin / HPLC

Cite this article

Download Citations
M Chun-li;JIO Zheng;YING Yin-qing;SHI Xio-Jin. Simultaneous Rapid Separation and Determination of Fosphenytoin,Phenytoin and Their Main Metabolite 4′-Hydroxyphenytoin in Human Plasma Using Reversed-Phase HPLC [J]. Chinese Pharmaceutical Journal, 2008, 43(22): 1743-1746

References

[1] BOUCHER B A,FELER C A,DEAN J C, et al. The safety,tolerability,and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients[J] . Pharmacotherapy,1996,16(4):638-645. [2] CWIK M J,LIANG M,DEYO K,et al. Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug,fosphenytoin in human plasma and ultrafiltrate[J] . J Chromatogr B Biomed Sci Appl,1997,693(2):407-414. [3] KUGLER A R,ANNESLEY T M,NORDBLOM G D,et al. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays[J] . Clin Chem,1998,44(7):1474-1480. [4] ROBERTS W L,DE B K,COLEMAN J P,et al. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin[J] . Clin Chem,1999,45(6 Pt 1):829-837.

Accesses

Citation

Detail

Sections
Recommended

/